Skip Navigation

Health: Drug development

pharmaCoMalariavaccine_shanghai_whotdrcrump

A rising generics industry in developing nations is helping secure access to cheap drugs for the world's poor. But controversies over patent rules could divert investment from already neglected diseases.

(Photo credit: WHO/TDR/Crump)

Opinions and Analysis

Translational research key to HIV vaccine

New funding mechanisms to support translational research are vital to develop a successful HIV vaccine, says Wayne C. Koff.

11 March 2010 | EN
Source: Nature

Universities should invest in neglected tropical diseases

Sandeep P. Kishore and colleagues call on universities to focus on research for neglected tropical diseases.

4 March 2010 | EN
Source: PLoS Neglected Tropical Diseases

Glaxo sets example to other drug companies

2 February 2010 | EN
Source: Nature

Policy Briefs

Policies to tackle HIV/AIDS

Reducing the global burden of HIV/AIDS relies on increased funding, more research and targeted prevention strategies.

1 December 2009 | EN
Source: Health Affairs


News and Features

Africa plans leap into drug R&D

African ministers and researchers meet this week to set out how to ensure the continent's drug research and development meets its needs.

18 February 2010 | EN

Sweet technique could keep virus vaccines cool

Suspending live virus vaccines in layers of sugar could prove an effective way of storing them without refrigeration.

17 February 2010 | EN